The extracorporeal membrane oxygenation market is expected to reach USD 346.1 million by 2024, according to a new report by Grand View Research, Inc. The growing number of respiratory failure cases and conditions, such as cardiopulmonary disease and Chronic Obstructive Pulmonary Disease (COPD) is anticipated to boost the market growth. For instance, according to the U.S. National Center for Health statistics, in the year 2014, there were about 149,205 deaths due to chronic lower respiratory disorders in the U.S.
Moreover, the increased adoption of ECMO machines in hospitals as a consequence ofthe medical community taking cognizance of the advantages related to the use of ECMO machines is anticipated to facilitate the emergence of this market during the forecast period.
Apart from the high applicability of these appliances in hospitals, technological advancements have played a pivotal role in further accelerating the usage of these devices. For instance, Medtronic’s Century heart lung machine, which consists of an arterial pump, data management system and cardioplegia delivery system, is employed to provide cardiopulmonary functional support to patients.
To request a sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
The veno-venous segment held a lucrative sharein 2015 among the modality types owing to its efficiency and reliability in furnishing gas exchange support.
The respiratory application segment held a remunerative share in 2015; this is attributed to the increasing number of patients suffering from respiratory conditions. Moreover, the technological advancement in the ECMO machines has further increased its adoption rate in hospitals for its use in respiratory failure conditions.
North America dominated the overall market with a revenue share of over 40.0% in 2015 owing to the presence of a well-developed infrastructure and a suitable reimbursement framework as well as the rise in number of supportive government funds.
However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 5.0% over the forecast period. Notable economic developments and the advancing healthcare system developed with the aid of supportive government initiatives are anticipated to assist the growth.
Moreover, the rising incidences of respiratory failure and cardiopulmonary diseases are identified as major impact rendering factors for the growth of this market. According to the World Health Organization, about 3 million deaths were reported globally due to COPD in the year 2012, which accounts for 6% of the total mortality.
Some leading players in this vertical include Maquet Holding B. V. & Co.KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group, Medtronic Plc, Terumo Cardiovascular Systems Corporation, and Nipro Medical Corporation.
These key players opt for technologically enhanced products and undertake collaborations with other companies to implement new product development strategy goals to sustain a competitive advantage in the industry. For instance, Medtronic Plc collaborated with Salyer Biomedical, LLC for the development of their product, Century heart lung machine.
Grand View Research has segmented the extracorporeal membrane oxygenation market on the basis of modality type, application, and region.
Global Extracorporeal Membrane Oxygenation Market, by Modality Revenue,(USD Million), 2013 - 2024
Global Extracorporeal Membrane Oxygenation Market, by ApplicationRevenue, (USD Million), 2013 - 2024
Extracorporeal cardiopulmonary resuscitation
Extracorporeal Membrane Oxygenation Market, byRegion, (USD Million), 2013 - 2024
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.